Google Inc. is teaming up with multiple sclerosis drugmaker Biogen Idec Inc. to study environmental and biological contributors to the debilitating disease’s progression, according to a Bloomberg Business article.

It’s the second major pharmaceutical partnership for the life science division of Google X labs.

Using sensors, software and data analysis tools, the companies will collect and sift through data from people with the disease, with the goal of figuring out why MS progresses differently from patient to patient.

Read full story here.